Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.Business Wire • 12/11/25
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in ItalyBusiness Wire • 12/09/25
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer SymposiumBusiness Wire • 12/05/25
Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 12/04/25
Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025Benzinga • 12/03/25
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data AccessBusiness Wire • 11/12/25
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response MonitoringBusiness Wire • 11/10/25
New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy ResponseBusiness Wire • 11/06/25
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 PatientsBusiness Wire • 11/05/25
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes OfferingBusiness Wire • 11/05/25
Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033Business Wire • 11/04/25
Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/30/25
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue GuidanceBusiness Wire • 10/29/25
Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker InsightsBusiness Wire • 10/27/25